Brevan Howard Capital Management’s Amdocs DOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$638K Buy
+9,776
New +$715K 0.01% 1160
2024
Q4
Sell
-7,250
Closed -$634K 1136
2024
Q3
$634K Sell
7,250
-2,323
-24% -$196K ﹤0.01% 618
2024
Q2
$756K Buy
9,573
+5,669
+145% +$466K 0.01% 468
2024
Q1
$353K Buy
3,904
+1,362
+54% +$124K ﹤0.01% 594
2023
Q4
$223K Buy
+2,542
New +$212K ﹤0.01% 848

Other funds holding DOX

Brevan Howard Capital Management's DOX Position: Q1 2026 in Review

Brevan Howard Capital Management opened a new position in Amdocs (DOX) in Q1 2026: 9,776 shares worth $638K. The stake represents 0.01% of the portfolio and ranks #1160 among its holdings. This is a return to the name: Brevan Howard Capital Management previously reported a position in DOX as recently as Q3 2024.

Brevan Howard Capital Management first reported a position in DOX in Q4 2023 and has held it in 5 quarters since. The position peaked at $756K in Q2 2024. 473 funds tracked by Wall St. Rank hold DOX as of Q1 2026.

  • Brevan Howard Capital Management held 9,776 shares of Amdocs worth $638K as of Q1 2026.
  • Amdocs was a new Brevan Howard Capital Management position in Q1 2026.
  • Amdocs made up 0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #1160 holding.
  • Brevan Howard Capital Management first reported a position in Amdocs in Q4 2023 and has held it in 5 quarters since.
  • Brevan Howard Capital Management's Amdocs position peaked at $756K in Q2 2024.
  • 473 funds tracked by Wall St. Rank held Amdocs as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.